173 related articles for article (PubMed ID: 9651530)
1. Isolation of a novel metabolizing system enriched in phase-II enzymes for short-term genotoxicity bioassays.
Paolini M; Pozzetti L; Silingardi P; Della Croce C; Bronzetti G; Cantelli-Forti G
Mutat Res; 1998 Mar; 413(3):205-17. PubMed ID: 9651530
[TBL] [Abstract][Full Text] [Related]
2. Wide spectrum detection of precarcinogens in short-term bioassays by simultaneous superinduction of multiple forms of cytochrome P450 isoenzymes.
Paolini M; Sapigni E; Hrelia P; Scotti M; Morotti M; Cantelli-Forti G
Carcinogenesis; 1991 May; 12(5):759-66. PubMed ID: 1903089
[TBL] [Abstract][Full Text] [Related]
3. Strategies for advancement of short-term mutagenicity tests: on the optimal ionic strength for the liver microsomal assay.
Paolini M; Mesirca R; Pozzetti L; Silingardi P; Grilli S; Cantelli-Forti G
Carcinogenesis; 1992 Aug; 13(8):1403-8. PubMed ID: 1499090
[TBL] [Abstract][Full Text] [Related]
4. Improvement of short-term tests for mutagenicity: on the optimal pH for the liver microsomal assay.
Paolini M; Sapigni E; Hrelia P; Grilli S; Lattanzi G; Cantelli-Forti G
Carcinogenesis; 1988 Dec; 9(12):2265-70. PubMed ID: 3191571
[TBL] [Abstract][Full Text] [Related]
5. N-benzylimidazole for preparation of S9 fraction with multi-induction of metabolizing enzymes in short-term genotoxicity assays.
Mori Y; Koide A; Fuwa K; Kobayashi Y
Mutagenesis; 2001 Nov; 16(6):479-86. PubMed ID: 11682638
[TBL] [Abstract][Full Text] [Related]
6. Expression and inducibility of drug-metabolizing enzymes in novel murine liver epithelial cell lines and their ability to activate procarcinogens.
Paolini M; Barone E; Corsi C; Paganin C; Revoltella RP
Cancer Res; 1991 Jan; 51(1):301-9. PubMed ID: 1988092
[TBL] [Abstract][Full Text] [Related]
7. Comparative effects of butylated hydroxyanisole on hepatic in vivo DNA binding and in vitro biotransformation of aflatoxin B1 in the rat and mouse.
Monroe DH; Eaton DL
Toxicol Appl Pharmacol; 1987 Sep; 90(3):401-9. PubMed ID: 3116723
[TBL] [Abstract][Full Text] [Related]
8. Stability of drug metabolizing enzymes during the incubation conditions of the liver microsomal assay with non-induced and induced mouse liver S-9 fractions.
Paolini M; Tonelli F; Bauer C; Corsi C; Bronzetti G
Carcinogenesis; 1987 Sep; 8(9):1179-84. PubMed ID: 3113750
[TBL] [Abstract][Full Text] [Related]
9. Effects of 2- and 3-tert-butyl-4-hydroxyanisole on glutathione S-transferase and epoxide hydrolase activities and sulfhydryl levels in liver and forestomach of mice.
Lam LK; Sparnins VL; Hochalter JB; Wattenberg LW
Cancer Res; 1981 Oct; 41(10):3940-3. PubMed ID: 7285002
[TBL] [Abstract][Full Text] [Related]
10. Isolation of S9 fractions from mouse and rat with increased enzyme activities after repeated administration of cytochrome P-450 and P-448 inducers.
Paolini M; Sapigni E; Hrelia P; Grilli S; Cantelli-Forti G
Mutagenesis; 1988 May; 3(3):239-43. PubMed ID: 3045486
[TBL] [Abstract][Full Text] [Related]
11. S9 induction by the combined treatment with cyclohexanol and albendazole.
Escobar-Garcia D; Camacho-Carranza R; Pérez I; Dorado V; Arriaga-Alba M; Espinosa-Aguirre JJ
Mutagenesis; 2001 Nov; 16(6):523-8. PubMed ID: 11682644
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of genotoxicity of tert.-butylhydroquinone in an hepatocyte-mediated assay with V79 Chinese hamster lung cells and in strain D7 of Saccharomyces cerevisiae.
Rogers CG; Boyes BG; Matula TI; Stapley R
Mutat Res; 1992 Jul; 280(1):17-27. PubMed ID: 1377341
[TBL] [Abstract][Full Text] [Related]
13. Effect of cigarette smoke on the mutagenic activation of various carcinogens in hamster.
Mori Y; Iimura K; Furukawa F; Nishikawa A; Takahashi M; Konishi Y
Mutat Res; 1995 Jan; 346(1):1-8. PubMed ID: 7530323
[TBL] [Abstract][Full Text] [Related]
14. Induction of phase I and phase II drug-metabolizing enzyme mRNA, protein, and activity by BHA, ethoxyquin, and oltipraz.
Buetler TM; Gallagher EP; Wang C; Stahl DL; Hayes JD; Eaton DL
Toxicol Appl Pharmacol; 1995 Nov; 135(1):45-57. PubMed ID: 7482539
[TBL] [Abstract][Full Text] [Related]
15. Mutagenicity of 3-tert-butyl-4-hydroxyanisole (BHA) and its metabolites in short-term tests in vitro.
Matsuoka A; Matsui M; Miyata N; Sofuni T; Ishidate M
Mutat Res; 1990 Jun; 241(2):125-32. PubMed ID: 2345551
[TBL] [Abstract][Full Text] [Related]
16. Dietary administration of 2(3)-t-butyl-4-hydroxyanisole elevates mouse liver microsome-mediated DNA binding and mutagenicity of aflatoxin B1.
Rahimtula AD; Martin M
Chem Biol Interact; 1984 Feb; 48(2):207-20. PubMed ID: 6421497
[TBL] [Abstract][Full Text] [Related]
17. Early events in the induction of rat hepatic UDP-glucuronosyltransferases, glutathione S-transferase, and microsomal epoxide hydrolase by 1,7-phenanthroline: comparison with oltipraz, tert-butyl-4-hydroxyanisole, and tert-butylhydroquinone.
Lamb JG; Franklin MR
Drug Metab Dispos; 2000 Sep; 28(9):1018-23. PubMed ID: 10950843
[TBL] [Abstract][Full Text] [Related]
18. Comparative genotoxicity of 3 procarcinogens in V79 cells as related to glutathione S-transferase activity of hepatocytes from untreated rats and those fed 2% butylated hydroxyanisole.
Rogers CG; Boyes BG; Lok E
Mutat Res; 1990 Jun; 244(2):163-71. PubMed ID: 2162483
[TBL] [Abstract][Full Text] [Related]
19. Butylated hydroxyanisole-induced alterations in cell kinetic parameters in rat forestomach in relation to its oxidative cytochrome P-450-mediated metabolism.
Verhagen H; Furnée C; Schutte B; Hermans RJ; Bosman FT; Blijham GH; ten Hoor F; Henderson PT; Kleinjans JC
Carcinogenesis; 1989 Oct; 10(10):1947-51. PubMed ID: 2791210
[TBL] [Abstract][Full Text] [Related]
20. Induction of hepatic glutathione S-transferase activity by butylated hydroxyanisole and conjugation of benzo[a]pyrene diol-epoxide.
Dock L; Martinez M; Jernström B
Carcinogenesis; 1984 Jun; 5(6):841-4. PubMed ID: 6426816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
